USP is supporting scientists, developers and manufacturers working worldwide to accelerate the development of safe and effective COVID-19 vaccines, medicines and other treatments. Trust Accelerated offers free USP technical expertise and resources to support an efficient path for regulatory predictability, while saving developers time and resources. Designed to fast-track bringing life-saving vaccines and treatments to market while ensuring quality development, the program builds the confidence and trust with healthcare practitioners and patients that is necessary for wide scale adoption. From discovery research and development to manufacturing and distribution, USP can advise on novel vaccines, monoclonal therapies, antiviral and cell therapies and immunoglobulins or convalescent plasma treatments. Additionally, we can support scaling up production of approved therapeutics.